Supernus Pharmaceuticals
SUPN
#4167
Rank
S$3.66 B
Marketcap
S$63.60
Share price
-0.14%
Change (1 day)
52.67%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total assets

Total assets on the balance sheet as of December 2025 : S$1.84 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total assets are S$1.84 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Supernus Pharmaceuticals - Total assets on balance sheet (from 2009 to 2025)

Total assets by year

Year Total assets Change
2025-12-31S$1.86 B0.29%
2024-12-31S$1.85 B10.2%
2023-12-31S$1.68 B-26.07%
2022-12-31S$2.28 B-0.05%
2021-12-31S$2.28 B14.76%
2020-12-31S$1.98 B27.21%
2019-12-31S$1.56 B17.1%
2018-12-31S$1.33 B135.3%
2017-12-31S$0.56 B26.71%
2016-12-31S$0.44 B67.92%
2015-12-31S$0.26 B47.63%
2014-12-31S$0.18 B28.52%
2013-12-31S$0.14 B22.35%
2012-12-31S$0.11 B65.18%
2011-12-31S$69.58 M14.91%
2010-12-31S$60.55 M-46.02%
2009-12-31S$0.11 B1.69%
2008-12-31S$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
S$253.19 B 13,613.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$110.21 B 5,869.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$142.95 B 7,642.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$114.44 B 6,098.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
S$10.01 B 442.46%๐Ÿ‡บ๐Ÿ‡ธ USA